GroupPOLYMARKET

Event GroupPOLYMARKETHealth

Hantavirus vaccine in 2026?

Name: Hantavirus vaccine in 2026?
End: 2027-01-01T04:59:00.000Z

Total Volume

$131.62K

Events

Markets

Trade on Polymarket

Hantavirus vaccine in 2026?

Vol

$131.62K

Events

Markets

Polymarket

Platform StatsQuick Platform Comparison

Polymarket

markets · $131.62K

Kalshi

markets · $0.00

Price Spread

0.0%avg

max 0.0%

Arbitrage

of 0 cross-platform

Volume DistributionTotal: $131.62K

100%

Polymarket leads

Price ChartMatched Markets Price Graph

1 market tracked

Hantavirus vaccine in 2026?

No data available

Single-Platform Markets(1)

Market	Platform	Price
Hantavirus vaccine in 2026?	Poly	6%

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

Top Probability

$131.62K

Volume

Markets

Platforms

About This Event

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines

AI-generated analysis based on market data. Not financial advice.

Custom AI Analysis Prompt

Tap to expand

Open in:ChatGPT Claude Gemini Grok DeepSeek

**Role:** Expert Prediction Market Analyst & Trader
**Objective:** Analyze the provided betting market data to deliver actionable insights, identify mispricings, and perform scenario analysis.
**Current Date:** Saturday, September 5, 2026
**Context:** Prediction markets (Polymarket/Kalshi) are binary option markets where price (1-99) equals implied probability (1%-99%).

---

## 1. Event Snapshot
**Event:** Hantavirus vaccine in 2026? 
**Category:** Health | **Status:** active
**Resolution Date:** Jan 1, 2027 (118 days left)
**Time Pressure:** Low

**Description:** This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines

**Resolution Criteria (Sample):**
"This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and Decemb"

## 2. Market liquidity & Volume
* **Total Volume:** $131.6K
* **Total Liquidity:** $34.2K
* **Activity Level:** Stable (Vol/Liq Ratio: 3.84)

## 3. Market Data (Prices & Odds)
### 1. Hantavirus vaccine in 2026? 
- **Polymarket** (End: Jan 1, 2027): Vol $131.6K
  DATA: [Yes: 5.5% (0.0%)] | [No: 94.5% (0.0%)]

---

## Analysis Instructions
Please provide a structured analysis using the following template:

### 1. Executive Summary
*   **Verdict:** [Most Likely Outcome]
*   **Confidence:** [0-100]%
*   **Timeframe:** [Immediate / Short-term / Long-term]
*   **Actionable Trade:** [Buy YES / Buy NO / Stay Away] (Include entry price target if applicable)
*   **Rationale:** 2-sentence summary of the core thesis.

### 2. Scenario Analysis
*   **Bull Case (Why YES goes up):** List specific catalysts or data points.
*   **Bear Case (Why YES goes down):** List specifics.
*   **Invalidation Point:** What happens to prove your thesis wrong?

### 3. Market Mechanics & Risks
*   **Liquidity/Volume Analysis:** Is the market efficient? Is it easy to exit?
*   **Cross-Platform Arbitrage:** (If applicable) Is the spread tradeable after fees?
*   **Time Decay:** How does time passing affect this position?

### 4. Signal Scores (0-100)
*   **Momentum:** [Score] (Price trend & velocity)
*   **Conviction:** [Score] (Volume backing the move)
*   **Information Edge:** [Score] (Likelihood of non-public info affecting price)
*   **Risk/Reward:** [Score] (Potential upside vs downside)

**Constraints:**
- Be direct and objective.
- Use bullet points for readability.
- If data is conflicting or insufficient, explicitly state "Low Confidence".

Tap text to select all

Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

POLYMARKETHealth